Your browser doesn't support javascript.
loading
Correction: The Meaning of Lymphadenopathies During Adjuvant Durvalumab After Chemoradiotherapy for Lung Cancer: Thinking Beyond Disease Progression.
Pantarotto, Marcos; Barata, Rita; Coelho, Ricardo; Sousa, Virginia; Carvalheiro, Catarina; Rolim, Ines; Garrido, Patricia; GIl, Nuno; Duarte-Ramos, Filipa; Tonin, Fernanda S.
Afiliação
  • Pantarotto M; Oncology, Champalimaud Foundation, Lisbon, PRT.
  • Barata R; Lung Unit, Champalimaud Foundation, Lisbon, PRT.
  • Coelho R; Lung Unit, Champalimaud Foundation, Lisbon, PRT.
  • Sousa V; Dermatology, Champalimaud Foundation, Lisbon, PRT.
  • Carvalheiro C; Lung Unit, Champalimaud Foundation, Lisbon, PRT.
  • Rolim I; Lung Unit, Champalimaud Foundation, Lisbon, PRT.
  • Garrido P; Lung Unit, Champalimaud Foundation, Lisbon, PRT.
  • GIl N; Lung Unit, Champalimaud Foundation, Lisbon, PRT.
  • Duarte-Ramos F; Faculty of Pharmacy, University of Lisbon, Lisbon, PRT.
  • Tonin FS; Health & Technology Research Center, Escola Superior de Tecnologia da Saúde de Lisboa, Instituto Politécnico de Lisboa, Lisbon, PRT.
Cureus ; 15(2): c101, 2023 Feb.
Article em En | MEDLINE | ID: mdl-36819952
[This corrects the article DOI: 10.7759/cureus.26729.].

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Cureus Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Cureus Ano de publicação: 2023 Tipo de documento: Article